The European Commission has approved Sanofi and AstraZeneca’s Beyfortus for the prevention of a common and highly contagious type of respiratory infection in infants.
https://www.pharmalive.com/wp-content/uploads/2022/05/EuropeanUnionFlagsMay32022.webp8091200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-11-04 04:20:482022-11-04 11:56:31Sanofi, Astra win EU approval for prevention of infant RSV
